Page last updated: 2024-08-23

dermatan sulfate and Hypertriglyceridemia

dermatan sulfate has been researched along with Hypertriglyceridemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Bruin, TW; Erkelens, DW; van Barlingen, HH; van Beek, A	1

Other Studies

1 other study(ies) available for dermatan sulfate and Hypertriglyceridemia

Article	Year
Danaparoid: an antithrombotic agent without major impact on triglyceride hydrolysis capacity in humans. Journal of internal medicine, 1997, Volume: 242, Issue:2 Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparinoids; Heparitin Sulfate; Humans; Hydrolysis; Hypertriglyceridemia; Lipoprotein Lipase; Reference Values; Renal Dialysis; Triglycerides	1997

Article

Year

Danaparoid: an antithrombotic agent without major impact on triglyceride hydrolysis capacity in humans.

Journal of internal medicine, 1997, Volume: 242, Issue:2

Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparinoids; Heparitin Sulfate; Humans; Hydrolysis; Hypertriglyceridemia; Lipoprotein Lipase; Reference Values; Renal Dialysis; Triglycerides

1997